• 1
    Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology 2005; 128: 1655-1667.
  • 2
    Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 2008; 248: 84-96.
  • 3
    Jarnagin WR, Bowne W, Klimstra DS, Ben-Porat L, Roggin K, Cymes K, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 2005; 241: 703-712; discussion 712-714.
  • 4
    Zen Y, Fujii T, Itatsu K, Nakamura K, Minato H, Kasashima S, et al. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. HEPATOLOGY 2006; 44: 1333-1343.
  • 5
    Ji Y, Fan J, Zhou J, Wang BS, Liu HB, Wu ZW, et al. Intraductal papillary neoplasms of bile duct. A distinct entity like its counterpart in pancreas. Histol Histopathol 2008; 23: 41-50.
  • 6
    Suh KS, Roh HR, Koh YT, Lee KU, Park YH, Kim SW. Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. HEPATOLOGY 2000; 31: 12-17.
  • 7
    Nanashima A, Kinoshita N, Nakanuma Y, Zen Y, Sumida Y, Abo T, et al. Clinicopathological features of “intraductal papillary neoplasm of the bile duct” and patient outcome after surgical resection. Hepatogastroenterology 2008; 55: 1167-1173.
  • 8
    Nakanuma Y. A novel approach to biliary tract pathology based on similarities to pancreatic counterparts: is the biliary tract an incomplete pancreas? Pathol Int 2010; 60: 419-429.
  • 9
    Zen Y, Sasaki M, Fujii T, Chen TC, Chen MF, Yeh TS, et al. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct—an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol 2006; 44: 350-358.
  • 10
    Bosman FT, Carneiro F, Hruban RH, eds. WHO Classification of Tumours of the Digestive System. World Health Organization Classification of Tumours. Lyon, France: IARC; 2010.
  • 11
    Nakanuma Y, Zen Y, Harada K, Ikeda H, Sato Y, Uehara T, et al. Tumorigenesis and phenotypic characteristics of mucin-producing bile duct tumors: an immunohistochemical approach. J Hepatobiliary Pancreat Sci 2010; 17: 211-222.
  • 12
    Zen Y, Pedica F, Patcha V, Capelli P, Zamboni G, Casaril A, et al. Mucinous cystic neoplasms of the liver: a clinicopatohlogical study and comparison with intraductal papillary neoplasms of the bile duct. Mod Pathol 2011; 24: 1079-1089.
  • 13
    Barton JG, Barrett DA, Maricevich MA, Schnelldorfer T, Wood CM, Smyrk TC, et al. Intraductal papillary mucinous neoplasm of the biliary tract: a real disease? HPB (Oxford) 2009; 11: 684-691.
  • 14
    Yeh CN, Jan YY, Yeh TS, Hwang TL, Chen MF. Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma. Ann Surg Oncol 2004; 11: 606-611.
  • 15
    Ohtsuka M, Kimura F, Shimizu H, Yoshidome H, Kato A, Yoshitomi H, et al. Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion. Am J Surg Pathol 2011; 35: 512-521.
  • 16
    Yang J, Wang W, Yan L. The clinicopathological features of intraductal papillary neoplasms of the bile duct in a Chinese population. Dig Liver Dis 2012; 44: 251-256.
  • 17
    Allen PJ, Reiner AS, Gonen M, Klimstra DK, Blumgart LH, Brennan MF, et al. Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. HPB (Oxford) 2008; 10: 341-346.
  • 18
    Choi SC, Lee JK, Jung JH, Lee JS, Lee KH, Lee KT, et al. The clinicopathological features of biliary intraductal papillary neoplasms according to the location of tumors. J Gastroenterol Hepatol 2010; 25: 725-730.
  • 19
    Matsumura N, Yamamoto M, Aruga A, Takasaki K, Nakano M. Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma. Cancer 2002; 94: 1770-1776.
  • 20
    Park SY, Roh SJ, Kim YN, Kim SZ, Park HS, Jang KY, et al. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact. Oncol Rep 2009; 22: 649-657.
  • 21
    Sclabas G, Barton J, Smyrk T, Barrett DA, Khan S, Kendrick ML, et al. Frequency of subtypes of biliary intraductal papillary mucinous neoplasm and their MUC1, MUC2, and DPC4 expression patters differ from pancreatic intraductal papillary mucinous neoplasm. J Am Coll Surg 2012; 214: 27-32.
  • 22
    Kim K, Lee J, Shin J, Lee KH, Lee KT, Sung JY, et al. Clinicopathologic features of intraductal papillary neoplasm of the bile duct according to histologic subtype. Am J Gastroenterol 2012; 107: 118-125.
  • 23
    Lee H, Rocha FG, Klimstra DS, Young GQ, Jarnagin WR, Katabi N. Intraductal papillary neoplasm of the bile duct (IPN): clinicopathologic study of 39 cases in comparison to pancreatic intraductal papillary mucinous neoplasm (IPMN) in a single North American institution [Abstract]. Lab Invest 2011; 91: 367A.
  • 24
    Kloek JJ, van der Gaag NA, Erdogan D, Rauws EA, Busch OR, Gouma DJ, et al. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas. Hum Pathol 2011; 42: 824-832.
  • 25
    Hong SM, Pawlik TM, Cho H, Aggarwal B, Goggins M, Hruban RH, et al. Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma. Surgery 2009; 146: 250-257.
  • 26
    Hong SM, Cho H, Moskaluk CA, Yu E. Measurement of the invasion depth of extrahepatic bile duct carcinoma: an alternative method overcoming the current T classification problems of the AJCC staging system. Am J Surg Pathol 2007; 31: 199-206.
  • 27
    Paik KY, Heo JS, Choi SH, Choi DW. Intraductal papillary neoplasm of the bile ducts: the clinical features and surgical outcome of 25 cases. J Surg Oncol 2008; 97: 508-512.
  • 28
    D'Angelica M, Brennan MF, Suriawinata AA, Klimstra D, Conlon KC. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg 2004; 239: 400-408.
  • 29
    Tajima Y, Kuroki T, Fukuda K, Tsuneoka N, Furui J, Kanematsu T. An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma. Br J Surg 2004; 91: 99-104.
  • 30
    Hoang MP, Murakata LA, Katabi N, Henson DE, Albores-Saavedra J. Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases. Mod Pathol 2002; 15: 1251-1258.
  • 31
    Hezel AF, Deshpande V, Zhu AX. Genetics of biliary tract cancers and emerging targeted therapies. J Clin Oncol 2010; 28: 3531-3540.
  • 32
    Albores-Saavedra J, Murakata L, Krueger JE, Henson DE. Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts. Cancer 2000; 89: 508-515.
  • 33
    Abraham SC, Lee JH, Boitnott JK, Argani P, Furth EE, Wu TT. Microsatellite instability in intraductal papillary neoplasms of the biliary tract. Mod Pathol 2002; 15: 1309-1317.
  • 34
    Abraham SC, Lee JH, Hruban RH, Argani P, Furth EE, Wu TT. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. Hum Pathol 2003; 34: 902-910.